Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Hypertension

Free Subscription Articles published in Lancet Retrieve available abstracts of 22 articles: HTML format

Single Articles

May 2025
1. FRIEDEN TR, Garg R, Moran AE, Whelton PK, et al
   Improved hypertension care requires measurement and management in health facilities, not mass screening.
   Lancet. 2025 May 7:S0140-6736(25)00561-6. doi: 10.1016/S0140-6736(25)00561.
   PubMed     Abstract available
   
   
   January 2025
2. MCCARTHY CP, Bruno RM, Rahimi K, Touyz RM, et al
   Global and European landscape of major hypertension guidelines.
   Lancet. 2025 Jan 15:S0140-6736(24)02795-8. doi: 10.1016/S0140-6736(24)02795.
   PubMed    
   
   
   October 2024
3. RODGERS A, Salam A, Schutte AE, Cushman WC, et al
   Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical tria
   Lancet. 2024;404:1536-1546.
   PubMed     Abstract available
   
   
   
4. ANTONOPOULOU M, Chliveros K
   A novel low-dose triple single-pill combination for hypertension.
   Lancet. 2024;404:1496-1498.
   PubMed    
   
   
   August 2024
5. 
   General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7.5 million participants.
   Lancet. 2024;404:851-863.
   PubMed     Abstract available
   
   
   July 2024
6. WERNHART M, Wiesinger C, Windpessl M, Madl-Liebenberger L, et al
   A visual diagnosis of phaeochromocytoma crisis characterised by cyclic fluctuations of blood pressure: be on the look-out for rapid changes.
   Lancet. 2024;404:375-376.
   PubMed    
   
   
   
7. RAHIMI K
   Mounting evidence in favour of the lower, the better blood pressure paradigm.
   Lancet. 2024;404:216-217.
   PubMed    
   
   
   June 2024
8. LIU J, Li Y, Ge J, Yan X, et al
   Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
   Lancet. 2024 Jun 27:S0140-6736(24)01028-6. doi: 10.1016/S0140-6736(24)01028.
   PubMed     Abstract available
   
   
   
9. HAYASHI SI, Kawano Y, Morishita R, Kusano KF, et al
   Time-lagged amelioration of vascular endothelial function in malignant hypertension: different organs improved at different rates.
   Lancet. 2024;403:2630-2631.
   PubMed    
   
   
   May 2024
10. JAFFAR S
    Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa - Authors' reply.
    Lancet. 2024;403:2292.
    PubMed    
    
    
    
11. CAI S, Xu Z, Zhao Y, Zuhlke L, et al
    Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.
    Lancet. 2024;403:2291.
    PubMed    
    
    
    
12. HAVLIR D, Kamya MR, Petersen M
    Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.
    Lancet. 2024;403:2291-2292.
    PubMed    
    
    
    March 2024
13. BAUDIN E, Goichot B, Berruti A, Hadoux J, et al
    Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
    Lancet. 2024;403:1061-1070.
    PubMed     Abstract available
    
    
    
14. DE LA SIERRA A, Staplin N, Ruilope LM, Baigent C, et al
    Ambulatory blood pressure monitoring and mortality - Authors' reply.
    Lancet. 2024;403:812.
    PubMed    
    
    
    
15. LIU W, Ge W, Fan X, Du Y, et al
    Ambulatory blood pressure monitoring and mortality.
    Lancet. 2024;403:811-812.
    PubMed    
    
    
    
16. MARTINEZ-GARCIA MA, Pengo MF, Parati G
    Ambulatory blood pressure monitoring and mortality.
    Lancet. 2024;403:810-811.
    PubMed    
    
    
    
17. CHU WM, Ho HE, Wei JC
    Ambulatory blood pressure monitoring and mortality.
    Lancet. 2024;403:810.
    PubMed    
    
    
    
18. LI SQ, Zhou JP, Wang Y, Li QY, et al
    Ambulatory blood pressure monitoring and mortality.
    Lancet. 2024;403:809-810.
    PubMed    
    
    
    November 2023
19. JACKSON R, Rodgers A
    The ESH guidelines and missed prevention opportunities.
    Lancet. 2023;402:1729-1730.
    PubMed    
    
    
    October 2023
20. MESSERLI FH, Bangalore S, Mandrola JM
    beta blockers switched to first-line therapy in hypertension.
    Lancet. 2023 Oct 13:S0140-6736(23)01733-6. doi: 10.1016/S0140-6736(23)01733.
    PubMed     Abstract available
    
    
    
21. KIVUYO S, Birungi J, Okebe J, Wang D, et al
    Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial.
    Lancet. 2023;402:1241-1250.
    PubMed     Abstract available
    
    
    
22. KISIGO GA, Peck RN
    Integrating HIV, hypertension, and diabetes primary care in Africa.
    Lancet. 2023;402:1211-1213.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.